Business Description
Gongwin Biopharm Holdings Co Ltd
ISIN : KYG409471060
Description
Gongwin Biopharm Holdings Co Ltd is a Taiwanese biotech and pharmaceutical company engaged in research and development of anti-cancer drugs. The company develops products related to central lung serious tracheal obstruction, primary liver cancer, malignant pleural effusion, and tracheal adenoid cystic carcinoma.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 12.83 | |||||
Equity-to-Asset | 0.86 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.99 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 44.93 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 175.3 | |||||
3-Year EBITDA Growth Rate | 4.4 | |||||
3-Year EPS without NRI Growth Rate | 2.7 | |||||
3-Year FCF Growth Rate | 4.1 | |||||
3-Year Book Growth Rate | 5.5 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.69 | |||||
9-Day RSI | 40.95 | |||||
14-Day RSI | 39.51 | |||||
6-1 Month Momentum % | -5.25 | |||||
12-1 Month Momentum % | -23.53 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 8.14 | |||||
Quick Ratio | 8.06 | |||||
Cash Ratio | 7.81 | |||||
Days Inventory | 569.09 | |||||
Days Sales Outstanding | 105.02 | |||||
Days Payable | 175.39 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.8 | |||||
Shareholder Yield % | 0.2 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 67.77 | |||||
Operating Margin % | -567.67 | |||||
Net Margin % | -393.14 | |||||
FCF Margin % | -492.86 | |||||
ROE % | -7.08 | |||||
ROA % | -6.09 | |||||
ROIC % | -29 | |||||
ROC (Joel Greenblatt) % | -53.24 | |||||
ROCE % | -6.93 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 632.56 | |||||
PB Ratio | 11.62 | |||||
Price-to-Tangible-Book | 11.61 | |||||
EV-to-EBIT | -165.55 | |||||
EV-to-EBITDA | -190.8 | |||||
EV-to-Revenue | 670.91 | |||||
EV-to-FCF | -135.06 | |||||
Price-to-Net-Current-Asset-Value | 16.98 | |||||
Price-to-Net-Cash | 17.89 | |||||
Earnings Yield (Greenblatt) % | -0.6 | |||||
FCF Yield % | -0.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gongwin Biopharm Holdings Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 24.359 | ||
EPS (TTM) (NT$) | -0.841 | ||
Beta | 0.07 | ||
Volatility % | 28.67 | ||
14-Day RSI | 39.51 | ||
14-Day ATR (NT$) | 6.439666 | ||
20-Day SMA (NT$) | 141.175 | ||
12-1 Month Momentum % | -23.53 | ||
52-Week Range (NT$) | 126 - 246.5 | ||
Shares Outstanding (Mil) | 127.51 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Gongwin Biopharm Holdings Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Gongwin Biopharm Holdings Co Ltd Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Gongwin Biopharm Holdings Co Ltd Frequently Asked Questions
What is Gongwin Biopharm Holdings Co Ltd(ROCO:6617)'s stock price today?
The current price of ROCO:6617 is NT$136.00. The 52 week high of ROCO:6617 is NT$246.50 and 52 week low is NT$126.00.
When is next earnings date of Gongwin Biopharm Holdings Co Ltd(ROCO:6617)?
The next earnings date of Gongwin Biopharm Holdings Co Ltd(ROCO:6617) is .
Does Gongwin Biopharm Holdings Co Ltd(ROCO:6617) pay dividends? If so, how much?
Gongwin Biopharm Holdings Co Ltd(ROCO:6617) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |